Incyte Corp/ US45337C1027 /
4/26/2024 9:59:59 PM | Chg. +0.49 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
51.65USD | +0.96% | 48,937 Turnover: 2.53 mill. |
-Bid Size: - | -Ask Size: - | 11.6 bill.USD | - | 19.36 |
GlobeNewswire
4/2
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
4/1
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
2/28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
1/9
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
12/9/2023
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
11/16/2023
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
11/2/2023
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update
GlobeNewswire
10/23/2023
Elevar Therapeutics Names Brian Cunningham Vice President of Sales and Kenneth Rankin Vice President...
GlobeNewswire
8/28/2023
Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer
GlobeNewswire
3/23/2022
RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation An...
GlobeNewswire
3/14/2022
STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
GlobeNewswire
3/1/2022
Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus R...
GlobeNewswire
2/28/2022
Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Up...
GlobeNewswire
2/24/2022
MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
GlobeNewswire
1/25/2022
Merus Appoints Shannon Campbell as Chief Commercial Officer and Regains Worldwide Rights to MCLA-145
GlobeNewswire
1/10/2022
Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agre...
GlobeNewswire
12/15/2021
AVITA Medical Completes Enrollment in Pivotal Trial Evaluating the RECELL® System for Repigmentation...
GlobeNewswire
12/6/2021
Merus Presents Clinical Data on MCLA-145 at the ESMO Immuno-Oncology Congress 2021